Report overview
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Drug R&D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Drug R&D. This report contains market size and forecasts of Artificial Intelligence Drug R&D in global, including the following market information:
Global Artificial Intelligence Drug R&D Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Artificial Intelligence Drug R&D market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AI Platfrom Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence Drug R&D include IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio, Google DeepMind, Genpact Cora, Cyclica Inc, QuantumBlack and Nq Medical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Intelligence Drug R&D companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence Drug R&D Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence Drug R&D Market Segment Percentages, by Type, 2022 (%)
AI Platfrom
Analytics Service
Global Artificial Intelligence Drug R&D Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence Drug R&D Market Segment Percentages, by Application, 2022 (%)
Drug Discovery
Precision Medicine
Global Artificial Intelligence Drug R&D Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Artificial Intelligence Drug R&D Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence Drug R&D revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Artificial Intelligence Drug R&D revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IBM Watson
BioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Artificial Intelligence Drug R&D, market overview.
Chapter 2: Global Artificial Intelligence Drug R&D market size in revenue.
Chapter 3: Detailed analysis of Artificial Intelligence Drug R&D company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Intelligence Drug R&D in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
